COLD AGGLUTININ DISEASE
Clinical trials for COLD AGGLUTININ DISEASE explained in plain language.
Never miss a new study
Get alerted when new COLD AGGLUTININ DISEASE trials appear
Sign up with your email to follow new studies for COLD AGGLUTININ DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug GL-0719 enters first human trials for rare blood disorder
Disease control Recruiting nowThis early-stage trial tests a new drug called GL-0719 in healthy volunteers and people with cold agglutinin disease, a rare condition where cold temperatures cause the immune system to destroy red blood cells. The study aims to check safety, how the drug moves through the body, …
Matched conditions: COLD AGGLUTININ DISEASE
Phase: PHASE1 • Sponsor: Gliknik Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New antibody therapy targets stubborn autoimmune blood diseases
Disease control Recruiting nowThis study tests an experimental drug called CM336 in people with relapsed or refractory autoimmune cytopenia, including ITP and autoimmune hemolytic anemia. CM336 is a bispecific antibody designed to target and eliminate certain immune cells. The trial will enroll 158 adults to …
Matched conditions: COLD AGGLUTININ DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC